Anavex Life Sciences Corp
F:12X1
Anavex Life Sciences Corp
F:12X1
Price:
4.343
EUR
10.59%
Market Cap:
€363.1m
Balance Sheet
Balance Sheet Decomposition
Anavex Life Sciences Corp
Anavex Life Sciences Corp
Balance Sheet Decomposition is not available for
Anavex Life Sciences Corp
Anavex Life Sciences Corp
Balance Sheet
Anavex Life Sciences Corp
Anavex Life Sciences Corp
Currency: USD
| Sep-2006 | Sep-2007 | Sep-2008 | Sep-2009 | Sep-2010 | Sep-2011 | Sep-2012 | Sep-2013 | Sep-2014 | Sep-2015 | Sep-2016 | Sep-2017 | Sep-2018 | Sep-2019 | Sep-2020 | Sep-2021 | Sep-2022 | Sep-2023 | Sep-2024 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
7
|
15
|
9
|
27
|
23
|
22
|
29
|
152
|
149
|
151
|
132
|
103
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
7
|
15
|
9
|
27
|
23
|
22
|
29
|
152
|
149
|
151
|
132
|
103
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
3
|
5
|
9
|
3
|
3
|
2
|
1
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
1
|
1
|
0
|
|
| Total Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
7
|
16
|
9
|
28
|
26
|
25
|
35
|
162
|
153
|
154
|
136
|
104
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
-25%
|
0
-33%
|
0
N/A
|
0
N/A
|
7
+1 750%
|
16
+109%
|
10
-39%
|
28
+193%
|
26
-6%
|
25
-3%
|
35
+36%
|
162
+368%
|
153
-6%
|
154
+1%
|
136
-12%
|
104
-23%
|
|
| Liabilities | |||||||||||||||||||||
| Accounts Payable |
0
|
1
|
1
|
2
|
1
|
0
|
3
|
2
|
1
|
3
|
3
|
4
|
3
|
4
|
4
|
5
|
4
|
4
|
10
|
4
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
3
|
6
|
6
|
7
|
5
|
4
|
|
| Short-Term Debt |
0
|
0
|
2
|
3
|
3
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
|
| Total Current Liabilities |
0
|
1
|
2
|
4
|
3
|
1
|
3
|
2
|
1
|
3
|
3
|
4
|
4
|
5
|
7
|
11
|
10
|
13
|
15
|
9
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
6
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
1
N/A
|
2
+360%
|
4
+87%
|
3
-23%
|
1
-61%
|
3
+123%
|
3
N/A
|
7
+148%
|
3
-63%
|
3
+19%
|
4
+13%
|
4
+8%
|
5
+28%
|
7
+46%
|
11
+48%
|
10
-6%
|
13
+23%
|
15
+22%
|
9
-42%
|
|
| Equity | |||||||||||||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
0
|
2
|
7
|
13
|
22
|
29
|
38
|
41
|
53
|
63
|
78
|
92
|
107
|
133
|
160
|
198
|
246
|
293
|
336
|
382
|
|
| Additional Paid In Capital |
0
|
1
|
5
|
9
|
19
|
28
|
35
|
39
|
52
|
74
|
84
|
116
|
129
|
154
|
187
|
348
|
388
|
435
|
456
|
477
|
|
| Total Equity |
0
N/A
|
1
N/A
|
2
-360%
|
4
-70%
|
3
+23%
|
1
+63%
|
3
-164%
|
3
+14%
|
0
N/A
|
13
+6 300%
|
6
-51%
|
24
+286%
|
22
-8%
|
20
-9%
|
27
+34%
|
151
+454%
|
143
-6%
|
142
0%
|
120
-15%
|
95
-21%
|
|
| Total Liabilities & Equity |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
-25%
|
0
-33%
|
0
N/A
|
0
N/A
|
7
+1 750%
|
16
+109%
|
10
-39%
|
28
+193%
|
26
-6%
|
25
-3%
|
35
+36%
|
162
+368%
|
153
-6%
|
154
+1%
|
136
-12%
|
104
-23%
|
|
| Shares Outstanding | |||||||||||||||||||||
| Common Shares Outstanding |
5
|
5
|
5
|
5
|
6
|
7
|
8
|
9
|
12
|
32
|
36
|
43
|
46
|
53
|
62
|
76
|
78
|
82
|
85
|
87
|
|
Switch to:
Switch to:
See Also
Discover More
